Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$569M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$353M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$306M |
| 4 |
Energy Transfer Partners
ET
|
+$303M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.14B |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$498M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$275M |
| 4 |
KLA
KLAC
|
+$274M |
| 5 |
ITC
ITC HOLDINGS CORP
ITC
|
+$270M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.04% |
| 2 | Technology | 4.19% |
| 3 | Energy | 3.93% |
| 4 | Healthcare | 3.01% |
| 5 | Consumer Discretionary | 2.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VG
5326
DELISTED
Vonage Holdings Corporation
VG
| $171K | ﹤0.01% |
24,941
+4,357
| +21% | +$28.8K |
|
|
DRRX
5327
DELISTED
DURECT Corp
DRRX
| $170K | ﹤0.01% |
12,735
+9,449
| +288% | +$121K |
|
5328
iShares JPMorgan EM High Yield Bond ETF
EMHY
$619M
| $170K | ﹤0.01% |
3,500
-500
| -13% | -$24.6K |
|
5329
CALL
Green Plains
GPRE
$1.21B
| $170K | ﹤0.01% |
6,100
-400
| -6% | -$10.6K |
|
5330
Vitamin Cottage Natural Grocers
NGVC
$741M
| $170K | ﹤0.01% |
14,328
+13,534
| +1,705% | +$161K |
|
5331
Par Pacific Holdings
PARR
$4.31B
| $170K | ﹤0.01% |
11,714
+10,896
| +1,332% | +$155K |
|
|
CAB
5332
CALL
DELISTED
Cabela's Inc
CAB
| $170K | ﹤0.01% |
2,900
-50,800
| -95% | -$3.15M |
|
|
LNW
5333
CALL
DELISTED
Light & Wonder
LNW
| $169K | ﹤0.01% |
12,100
+10,000
| +476% | +$137K |
|
5334
Pediatrix Medical
MD
$2.17B
| $169K | ﹤0.01% |
2,538
+136
| +6% | +$8.85K |
|
5335
Cohen & Steers Infrastructure Fund
UTF
$3.11B
| $169K | ﹤0.01% |
8,705
+3,994
| +85% | +$80.2K |
|
|
MYOK
5336
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $169K | ﹤0.01% |
13,065
+12,141
| +1,314% | +$187K |
|
|
CTLP
5337
DELISTED
Cantaloupe
CTLP
| $168K | ﹤0.01% |
39,078
+33,142
| +558% | +$151K |
|
5338
CALL
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.07B
| $168K | ﹤0.01% |
1,533
+933
| +156% | +$102K |
|
5339
CALL
PTC Therapeutics
PTCT
$6.26B
| $168K | ﹤0.01% |
15,400
-3,000
| -16% | -$31.5K |
|
5340
Protagonist Therapeutics
PTGX
$8.92B
| $168K | ﹤0.01% |
7,644
+7,023
| +1,131% | +$157K |
|
|
SIOX
5341
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $168K | ﹤0.01% |
1,689
+1,418
| +523% | +$149K |
|
|
MN
5342
DELISTED
MANNING & NAPIER, INC.
MN
| $168K | ﹤0.01% |
22,242
+1,272
| +6% | +$9.41K |
|
5343
Franklin Covey
FC
$243M
| $167K | ﹤0.01% |
8,292
+7,456
| +892% | +$145K |
|
5344
First Internet Bancorp
INBK
$229M
| $167K | ﹤0.01% |
5,229
+1,739
| +50% | +$47.4K |
|
5345
Rapid7
RPD
$634M
| $167K | ﹤0.01% |
13,738
+11,775
| +600% | +$159K |
|
5346
Superior Group of Companies
SGC
$192M
| $167K | ﹤0.01% |
8,530
+8,230
| +2,743% | +$155K |
|
|
LLL
5347
PUT
DELISTED
L3 Technologies, Inc.
LLL
| $167K | ﹤0.01% |
1,100
-5,100
| -82% | -$769K |
|
|
FOLD
5348
PUT
DELISTED
Amicus Therapeutics
FOLD
| $166K | ﹤0.01% |
33,400
+15,500
| +87% | +$107K |
|
5349
CALL
Synaptics
SYNA
$4.25B
| $166K | ﹤0.01% |
3,100
-3,300
| -52% | -$191K |
|
|
GEN
5350
DELISTED
Genesis Healthcare, Inc.
GEN
| $166K | ﹤0.01% |
39,099
+34,629
| +775% | +$114K |
|
Similar funds
Citigroup's Q4 2016 Portfolio in Review
As of Q4 2016, Citigroup held 7,585 positions worth $111B, up 3.7% from $107B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Citigroup's Q4 2016 filing shows 495 new, 3,908 increased, 2,242 reduced and 328 closed positions. Its largest new stake was VelocityShares3x Long Crude Oil ETNs linked to the S&P GSCI Crude Oil Index ER: 1,066,000 shares worth $29.5M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.14B.
By sector, the portfolio is most concentrated in Financials at 5% of assets, up from 3.8% a quarter earlier, followed by Technology and Energy.
- Citigroup's largest Q4 2016 buy was VelocityShares3x Long Crude Oil ETNs linked to the S&P GSCI Crude Oil Index ER: 1,066,000 shares worth $29.5M.
- Citigroup added most to iShares Russell 2000 ETF in Q4 2016, an estimated $569M increase.
- Citigroup's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.14B.
- Citigroup fully exited ITC HOLDINGS CORP in Q4 2016, selling an estimated $270M.
- Citigroup's ten largest holdings make up 27% of its $111B portfolio in Q4 2016.
- Citigroup opened 495 new positions and closed 328 in Q4 2016.
- Citigroup's portfolio value rose 3.7% quarter-over-quarter to $111B.
Based on Citigroup's 13F filing for Q4 2016, filed 10 Feb 2017.